Epogen Market, By Indication (Anemia Due to Chronic Kidney Disease, Anemia Due to Zidovudine in Patients with HIV Infection, Anemia Due to Chemotherapy in Patients with Cancer, Reduction of Allogeneic Red Blood Cell Transfusions in Patients, Undergoing Elective, Noncardiac, and Nonvascular Surgery), By Strength (2,000 Units/mL, 3,000 Units/mL, 4,000 Units/mL, 10,000 Units/mL, 20,000 Units/mL, and 40,000 Units/mL), By Dosage Form (Injection (Single-dose vials and Multi-dose vials)), By Route of Administration (Intravenous and Subcutaneous), By End User (Hospitals, Dialysis Centers, Oncology Clinics & Cancer Treatment Centers, Specialty Pharmacies & Home Healthcare Providers, Long-Term Care Facilities & Nursing Homes, and Others (Research Institutes, etc.)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Select a License Type that Suits your Business Needs
US$ 2,200
Two thousand two hundred dollars
Single User License
( Full Report )
US$ 4,500
Four thousand five hundred dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
Seven thousand dollars
Corporate User License
( Full Report )
US$ 10000
Ten thousand dollars
Client Testimonials
Client Testimonials
Our Clients
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

860519526
9001:2015
27001:2022